Back to Journals » Patient Preference and Adherence » Volume 2

Impact of clinical pharmacy services on renal transplant recipients’ adherence and outcomes

Authors Chisholm-Burns MA, Spivey CA, Garrett C, McGinty H, Mulloy LL

Published 17 October 2008 Volume 2008:2 Pages 287—292

DOI https://doi.org/10.2147/PPA.S4174

Review by Single-blind

Peer reviewer comments 3

Marie A Chisholm-Burns1, Christina A Spivey1, Charlene Garrett2, Herbert McGinty2, Laura L Mulloy3

1Department of Pharmacy Practice and Science, The University of Arizona College of Pharmacy, Tuscon, AZ, USA; 2Medication Access Program (MAP), University of Georgia College of Pharmacy, Athens, GA, USA; 3Section of Nephrology, Hypertension and Transplantation Medicine, Medical College of Georgia School of Medicine, Augusta, GA, USA

Abstract: The purpose of this article is to provide a description of a clinical pharmacy services program implemented in a renal transplant clinic to improve medication access and adherence as well as health and economic outcomes among renal transplant recipients (RTRs). Following a team-based planning process and an informal survey of RTRs, a clinical pharmacy service intervention was implemented in the Medical College of Georgia renal transplant clinic. As part of the intervention, a clinical pharmacist reviewed and optimized medication therapy, provided instructions on how to take medication, and assisted with enrollment into medication assistance programs. Significant differences were found between RTRs who did and did not receive clinical pharmacy services on measures of adherence, health, economics, and quality of life. Clinical pharmacy services, as described in this article, have a positive impact on renal transplant recipients’ medication adherence, health and economic outcomes, and health-related quality of life. The findings described here suggest that clinical pharmacy services are a viable and effective option for improving care for RTRs in an outpatient clinic setting.

Keywords: renal transplant recipients, immunosuppressant therapy adherence, health outcomes, economic outcomes

 

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]